BKYI

BIO-Key International Inc
NASDAQINDUSTRIALSSECURITY & PROTECTION SERVICES

Key Statistics

Market Cap
$5.76M
P/E Ratio
EPS
$-6.90
Beta
0.45
52W High
$13.80
52W Low
$3.45
50-Day MA
$5.95
200-Day MA
$6.94
Dividend Yield
Profit Margin
-75.30%
Forward P/E
PEG Ratio
0.00

About BIO-Key International Inc

BIO-key International, Inc., develops and markets biometric fingerprint identification technology, enterprise-ready identity access management solutions, and software solutions for commercial, government, and educational clients in the United States and internationally. The company is headquartered in Wall, New Jersey.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$6.10M
Gross Profit (TTM)$4.72M
EBITDA$-3.91M
Operating Margin-132.40%
Return on Equity-80.20%
Return on Assets-27.30%
Revenue/Share (TTM)$9.17
Book Value$7.07
Price-to-Book0.74
Price-to-Sales (TTM)0.94
EV/Revenue0.605
EV/EBITDA-0.74
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-15.10%
Shares Outstanding$1.09M
Float961,570
% Insiders11.39%
% Institutions4.79%

Historical Volatility

HV 10-Day
112.31%
HV 20-Day
86.52%
HV 30-Day
82.28%
HV 60-Day
76.54%
HV Rank

Volatility is currently expanding

Latest News

BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th

HOLMDEL, N.J., July 07, 2026 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, today announced that The Nasdaq Stock Market LLC has notified it that the trading of its common stock will recommence on the Nasdaq Capital Market effective with markets' opening on Wednesday, July 8, 2026.

GlobeNewsWire7/7/2026Neutral
BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filing

HOLMDEL, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc.  (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced today that it has received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026.

GlobeNewsWire6/10/2026Neutral
BIO-key Shares Expected to Temporarily Move to OTC™ Markets Tomorrow, Wednesday May 13th Following Nasdaq Suspension After Today's Market Close; BIO-key is Seeking to Restore Nasdaq Listing Expeditiously

HOLMDEL, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced that it has received written notification from The Nasdaq Stock Market LLC that the trading of its common stock will be suspended on Nasdaq effective with markets' close today, Tuesday, May 12, 2026.

GlobeNewsWire5/12/2026Neutral

More INDUSTRIALS Stocks

Data last updated: 5/13/2026